Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Schrodinger Inc (NQ: SDGR ) 17.51 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Schrodinger Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) September 18, 2024 From Schrödinger Via Business Wire AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week September 15, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual... Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th September 10, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual... Via Talk Markets Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! September 05, 2024 The August ISM manufacturing index reported on Tuesday that figures came in below consensus expectation. That raised fears about the strength of the economy, driving down our Our AI-Focused Drug... Via Talk Markets Topics Economy Exposures Economy What Analysts Are Saying About Schrodinger Stock July 11, 2024 Via Benzinga Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week August 27, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030. Via Talk Markets Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 16, 2024 From Schrödinger Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD August 14, 2024 The AI-powered drug discovery process is expected to grow by a 30% CAGR between now and 2030 which should result in approximately 50 novel therapies and generate annual sales in excess of $50 billion... Via Talk Markets Schrödinger to Present at Morgan Stanley Global Healthcare Conference August 14, 2024 From Schrödinger Via Business Wire The 3 Best Med Tech Stocks to Buy Now August 05, 2024 Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. Via InvestorPlace SDGR Stock Earnings: Schrodinger Beats EPS, Beats Revenue for Q2 2024 July 31, 2024 SDGR stock results show that Schrodinger beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Schrödinger Reports Strong Second Quarter 2024 Financial Results July 31, 2024 From Schrödinger Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030. Via Talk Markets 3 Small-Cap Stocks to Buy at a 52-Week Low July 27, 2024 The Russell 2000 is hinting at sector rotation, meaning it’s time for bargain hunters to look for small-cap stocks at 52-week lows Via InvestorPlace Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology July 26, 2024 From Schrödinger Via Business Wire 3 Stocks That Could Benefit Big Time From Coming Interest Rate Cuts July 22, 2024 The Fed is widely expected to cut interest rates a great deal. Here are three stocks to buy to benefit from these interest rate cuts. Via InvestorPlace Topics Economy Exposures Interest Rates AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 To capitalize on the transition to more AI-focused drug development investors need to understand the drug development process and the financial health and market potential of those companies under... Via Talk Markets Schrödinger to Announce Second Quarter 2024 Financial Results on July 31 July 17, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 16, 2024 From Schrödinger Via Business Wire Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... Via Talk Markets Simulations Plus Stock Drops 15% Despite EPS Beat July 05, 2024 Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence 3 Top-Rated Gene Editing Stocks Actually Making Money July 03, 2024 Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. Via InvestorPlace Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 The global Via Talk Markets Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 14, 2024 From Schrödinger Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 The global Via Talk Markets The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May June 01, 2024 The 7 AI categories we track dropped, down 4.3% this week, and are now only up 1.3% for the month of May. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Schrödinger to Present at Jefferies Global Healthcare Conference May 22, 2024 From Schrödinger Via Business Wire Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 17, 2024 From Schrödinger Via Business Wire 7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs May 16, 2024 AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.